Microneedling Plus the Universal Peel For Acne Scarring
- Conditions
- Acne Scarring
- Interventions
- Drug: Universal PeelProcedure: MicroneedlingDrug: Post-Microneedling Skin CareDrug: Post-Universal Peel Skin Care
- Registration Number
- NCT02174393
- Lead Sponsor
- Englewood Hospital and Medical Center
- Brief Summary
Acne is a prevalent disorder mostly witnessed in adolescents, but can be seen in adults. Early treatment is imperative to reduce acne scarring which can appear with atrophic lesions, and depending on the skin type, significant erythema (redness) or post-inflammatory hyperpigmentation. A multi-modality approach to treatment is necessary when dealing with the aforementioned types of lesions. Pharmacologic management is essential, but safe procedural therapies are also necessary specifically with darker skinned individuals.
Percutaneous collagen induction therapy (PCIT) is a non-invasive treatment achieved by using a micro-needling device, which is safe and effective in causing "micro-wounds" into the dermis thereby initiating wound healing followed by collagen production. This is an ideal treatment for acne scarring, re-texturizing of the skin, and hyperpigmentation for all skin types . Currently there are very few studies evaluating the safety and efficacy of microneedling and chemical peels in skin types III-VI.
The aim of this study is to evaluate the effects of the combination of microneedling and chemical peel for the treatment of acne scars in skin types III-VI.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 15
- Subject > 18 and < 60 years of age.
- Subject has skin type III, IV, V, or VI as defined by the Fitzpatrick Classification Scale.
- Subject has acne scarring as defined by the Goodman and Baron Grading System.
- Subject currently has moderate to severe acne on the face.
- Subject has an active infection.
- Subject is pregnant or lactating.
- Subject has a history of a bleeding disorder.
- Subject is taking an anti-coagulant.
- Subject has a history of keloidal tendency.
- Subject has received ablative or non-ablative laser treatments in the previous 6 months.
- Subject has taken Accutane within the previous 3 months.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Microneedling Plus Universal Peel Universal Peel (1) Microneedling treatment by the MicroPen with a Post-Microneedling Skin Care Regimen and the (2) Universal Peel by Topix with a Post-Universal Peel Skin Care Regimen will both be performed on a monthly basis for a total of three treatment sessions each. Microneedling will be done on Study Weeks 1, 5, and 9. Universal Peel will be done on Study Weeks 3, 7, and 11. Microneedling Plus Universal Peel Microneedling (1) Microneedling treatment by the MicroPen with a Post-Microneedling Skin Care Regimen and the (2) Universal Peel by Topix with a Post-Universal Peel Skin Care Regimen will both be performed on a monthly basis for a total of three treatment sessions each. Microneedling will be done on Study Weeks 1, 5, and 9. Universal Peel will be done on Study Weeks 3, 7, and 11. Microneedling Plus Universal Peel Post-Microneedling Skin Care (1) Microneedling treatment by the MicroPen with a Post-Microneedling Skin Care Regimen and the (2) Universal Peel by Topix with a Post-Universal Peel Skin Care Regimen will both be performed on a monthly basis for a total of three treatment sessions each. Microneedling will be done on Study Weeks 1, 5, and 9. Universal Peel will be done on Study Weeks 3, 7, and 11. Microneedling Plus Universal Peel Post-Universal Peel Skin Care (1) Microneedling treatment by the MicroPen with a Post-Microneedling Skin Care Regimen and the (2) Universal Peel by Topix with a Post-Universal Peel Skin Care Regimen will both be performed on a monthly basis for a total of three treatment sessions each. Microneedling will be done on Study Weeks 1, 5, and 9. Universal Peel will be done on Study Weeks 3, 7, and 11.
- Primary Outcome Measures
Name Time Method Improvement in the appearance of acne scarring as measured by The Goodman and Baron Grading Scale. 6 months The scale will be completed at every office visit over the 6 month study (Baseline, Weeks 1, 3, 5, 7, 9, 11, and 17).
Improvement in the appearance of acne scarring as measured by the 4 Point Scar Scale. 6 Months The scale will be completed at each office visit during the 6 month study (Baseline, Weeks 1, 3, 5, 7, 9, 11, and 17).
Improvement in the appearance of acne scarring as measured by the Global Assessment. 6 months The Global Assessment of Improvement will be completed at Week 17.
- Secondary Outcome Measures
Name Time Method Improvement in the appearance of acne scarring as subjectively measured through digital pictures. 6 months Pictures of the subject will be taken by the Principal Investigator at every office visit during the 6 month study (Baseline, Weeks 1, 3, 5, 7, 9, 11, and 17).
Patient-reported improvement in the appearance of acne scarring as measured by the Cardiff Index. 6 months The Cardiff Index will be completed at Baseline and Week 17.
Patient reported improvement in appearance of acne scarring a measured by pre and post-treatment questionnaires. 6 months Subject will complete a pre-treatment questionnaire at Baseline and post-treatment questionnaires at Weeks 7 and 17.
Trial Locations
- Locations (1)
Bergen Dermatology
🇺🇸Englewood Cliffs, New Jersey, United States